Read More

NightHawk Biosciences Announces Planned Name Change To Scorpius Holdings, Reflecting Successful Transition To A Large Molecule Biomanufacturing CDMO; In Connection With The Name Change, The Company’s Ticker Will Change To “SCPX”

NightHawk Biosciences (NYSE:NHWK, NHWK)), an integrated contract development and manufacturing organization (CDMO), today announced that it is changing the name of the Company to Scorpius Holdings, Inc. ("Scorpius") to

NHWK

Read More

NightHawk Biosciences Announces Major Milestone With Completion Of Manufacturing Run For A Premier U.S.-Based Biopharmaceutical Company; Advances Multi-million Dollar Biomanufacturing Contract Awarded Earlier This Year

Manufacturing run at Scorpius' state-of-the-art San Antonio microbial facility sets the stage for commercial manufacturing Advances multi-million dollar biomanufacturing contract awarded earlier this year;set to

NHWK